Search
Now showing items 1-8 of 8
Thrombin generation, D-dimer and protein S in normal uncomplicated pregnancy
(Pergamon-Elsevier Science Ltd, Oxford, 2015)
The presence of prothrombotic mutations and a higher FVIII activity contribute to thrombosis development during the breast cancer treatment
(Pergamon-Elsevier Science Ltd, Oxford, 2014)
Risk factors for thrombosis in acute promyelocytic leukemia
(Pergamon-Elsevier Science Ltd, Oxford, 2014)
Poor pregnancy outcome in women with homozygous type-II HBS antithrombin deficiency
(Pergamon-Elsevier Science Ltd, Oxford, 2014)
Clinical characteristics of the first thrombosis process among young women and those over 45 years
(Pergamon-Elsevier Science Ltd, Oxford, 2013)
The c20068t gene variant in the 3 ' end of the prothrombin gene is the risk factor for recurrent pregnancy loss
(Pergamon-Elsevier Science Ltd, Oxford, 2014)
High prophylactic LMWH dose successfully suppressed hemostatic activation in pregnant woman with a new prothrombin c.1787G gt Amutation
(Pergamon-Elsevier Science Ltd, Oxford, 2015)
Thrombotic events in acute promyelocytic leukemia
(Pergamon-Elsevier Science Ltd, Oxford, 2015)
Introduction: Thrombotic events (TE) appear to be more common in acute promyelocytic leukemia (APL) than in other acute leukemias, with reported prevalence ranging from 2 to 10-15%. Materials and Methods: We retrospectively ...